Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dae Wook Hwang

Showing results (211-220 of 227) with videos related to

Pageof 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 3, 2019
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarkerHeejung Chae, Deokhoon Kim, Changhoon Yoo, et al.
Investigational New Drugs|August 8, 2017
Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testingKyoungmin Lee, Changhoon Yoo, Kyu-Pyo Kim, et al.
British Journal of Cancer|May 21, 2020
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysisChanghoon Yoo, Sang Soo Lee, Ki Byung Song, et al.
Plos One|April 13, 2019
Stereotactic body radiation therapy for locally advanced pancreatic cancerJinhong Jung, Sang Min Yoon, Jin-Hong Park, et al.
Annals of Surgical Oncology|May 10, 2021
Minimally Invasive Versus Open Pancreatectomy for Right-Sided and Left-Sided G1/G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Multicenter Matched Analysis with an Inverse Probability of Treatment-Weighting MethodHo Kyoung Hwang, Ki Byung Song, Minsu Park, et al.
Cancers|February 25, 2022
Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional RegistriesIn Woong Han, Jangho Park, Eun Young Park, et al.
Journal of Hepatology|August 13, 2025
Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinomaHyehyun Jeong, Ji-Hye Oh, Hee-Sung Ahn, et al.
Journal of Hepatology|November 12, 2024
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinomaChanghoon Yoo, Hyehyun Jeong, Jae Ho Jeong, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|January 29, 2024
Are enhanced recovery protocols after pancreatoduodenectomy still efficient when applied in elderly patients? A systematic review and individual patient data meta-analysisChristoph Kuemmerli, Gianpaolo Balzano, Stefan A Bouwense, et al.
Gut and Liver|May 4, 2021
Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)Jae Seung Kang, Lydia Mok, Jin Seok Heo, et al.
Pageof 23

Showing results (211-220 of 227) with videos related to

Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|September 3, 2019
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarkerHeejung Chae, Deokhoon Kim, Changhoon Yoo, et al.
Investigational New Drugs|August 8, 2017
Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testingKyoungmin Lee, Changhoon Yoo, Kyu-Pyo Kim, et al.
British Journal of Cancer|May 21, 2020
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysisChanghoon Yoo, Sang Soo Lee, Ki Byung Song, et al.
Plos One|April 13, 2019
Stereotactic body radiation therapy for locally advanced pancreatic cancerJinhong Jung, Sang Min Yoon, Jin-Hong Park, et al.
Annals of Surgical Oncology|May 10, 2021
Minimally Invasive Versus Open Pancreatectomy for Right-Sided and Left-Sided G1/G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Multicenter Matched Analysis with an Inverse Probability of Treatment-Weighting MethodHo Kyoung Hwang, Ki Byung Song, Minsu Park, et al.
Cancers|February 25, 2022
Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional RegistriesIn Woong Han, Jangho Park, Eun Young Park, et al.
Journal of Hepatology|August 13, 2025
Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinomaHyehyun Jeong, Ji-Hye Oh, Hee-Sung Ahn, et al.
Journal of Hepatology|November 12, 2024
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinomaChanghoon Yoo, Hyehyun Jeong, Jae Ho Jeong, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|January 29, 2024
Are enhanced recovery protocols after pancreatoduodenectomy still efficient when applied in elderly patients? A systematic review and individual patient data meta-analysisChristoph Kuemmerli, Gianpaolo Balzano, Stefan A Bouwense, et al.
Gut and Liver|May 4, 2021
Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)Jae Seung Kang, Lydia Mok, Jin Seok Heo, et al.
Pageof 23